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A B S T R A C T
Zika virus is an emerging arbovirus transmitted by Aedes sp. mosquitoes like the Dengue and
Chikungunya viruses. Zika virus was until recently considered a mild pathogenic mosquito-borne
ﬂavivirus with very few reported benign human infections. In 2007, an epidemic in Micronesia initiated
the turnover in the epidemiological history of Zika virus and more recently, the potential association
with congenital microcephaly cases in Brazil 2015, still under investigation, led the World Health
Organization (WHO) to declare a Public Health Emergency of International Concern on February 1, 2016.
Here, we present the clinical and laboratory aspects related to the ﬁrst four imported human cases of
Zika virus in Portugal from Brazil, and alert, regarding the high level of traveling between Portugal and
Brazil, and the ongoing expansion of this virus in the Americas, for the threat for Zika virus introduction
in Europe and the possible introduction to Madeira Island where Aedes aegypti is present.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Zika virus (ZIKV) is a member of the Spondweni serocomplex
within the genus Flavivirus ﬁrstly isolated in 1947 from a sentinel
rhesus monkey in Zika Forest, Uganda [1]. There are two main
lineages of ZIKV, the African and the Asian lineages [2,3].
ZIKV was until recently considered a mildly pathogenic
mosquito-borne ﬂavivirus with very few reported human cases
of self-limiting acute febrile illnesses most often with maculo-
papular rash, headache, arthralgia, myalgia and conjunctivitis
[4–6]. In 2007, after an epidemic in Micronesia [7,8] the geographic
range of ZIKV expanded dramatically. In 2013–2014, through an
outbreak in French Polynesia a link relating ZIKV infections with the
increased incidence of Guillan–Barre´ syndrome and other neuro-
logical complications was assumed mainly in regions with previous
dengue epidemics [9,10]. The potential association with congenital
microcephaly cases in Brazil 2015 [11,12], still under investigation,
raise several questions, that undoubtedly increase public health
awareness to ZIKV, and led the WHO declaration, considering ‘‘the* Corresponding author at: Centro de Estudos de Vectores e Doenc¸as Infecciosas,
Instituto Nacional de Sau´de Dr. Ricardo Jorge, Avenida Liberdade 5, 2965-575 A´guas
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4.0/).recent cluster of microcephaly cases and other neurological
disorders reported in Brazil, following a similar cluster in French
Polynesia’’ a Public Health Emergency of International Concern on
February 1, 2016 [13]. As most pathogenic ﬂavivirus, only a small
percentage of ZIKV cases (estimated to be about 25%) are
symptomatic [8], and transmission via transfusion of infected blood
or organs donations, or sexual transmission, remains a risk.
Here we report four cases of patients with Zika infection,
diagnosed in Portugal, shortly after returning from Brazil. In June
2015, Zika virus infection was serologically detected for the ﬁrst
time in a couple returning from Ceara´ state and in the end of 2015,
Zika virus was detected in the urine samples of two patients after
visiting Rio de Janeiro and Espı´rito Santo states.
Case presentation
Cases 1 and 2
In June 2015, a Portuguese couple in their sixties with no past
medical history, traveled to northeast Brazil (Ceara´ State) on
holidays for two weeks. At midstay (day 1 of illness) both
developed fever (38.3 8C) and arthralgias. The fever lasted for three
days, responding to acetaminophen and ibuprofen. Arthralgias
were located in the hands, wrists and ankles, lasting till admission.
At day 4, they complained of macular rash with no pruritus,e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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in the man. Both reported anorexia with weight loss and the man
felt asthenic.
Upon admission in Portugal, on day 11 of illness, they both
appeared sick and tired with dry mucosae and lower extremity
rashes below the knee. The laboratory ﬁndings in the hospital were
within normal limits, except for C-reactive protein 10.6 mg/L
(norm: <5 mg/L) and slightly elevated aminotransferase, ALT 58 U/
L for the man and 52 U/L for the woman (norm: 4–50 U/L). Speciﬁc
diagnostic was requested for Dengue, Zika and Chikungunya
viruses. Serology was IgM positive for Zika virus in both patients.
The patients recovered without complications.
Case 3
A 62 year old Brazilian woman, with a past medical history of
systemic lupus erythematosus, ﬁbromyalgia, cardiomyopathy and
hyperuricemia who had lived in Portugal for the last 15 years,
developed fever, myalgias and arthralgias on November 22 2015
after a month trip to Rio de Janeiro and Espı´rito Santo states
(southeast Brazil). The next day, she developed a maculopapularTable 1
Characteristics of the four imported cases of Zika virus infections based on epidemiolo
Case 1 
Epidemiological data
Gender Male 
Age 61 years 
Date of return 26 Jun. 2015 
Onset of symptoms 19 Jun. 2015 
Clinical data
Fever 3 days 
Arthralgia Hands, wrists
and ankles
Myalgias No 
Skin rash Maculopapular:
trunk
Anorexia Yes 
Asthenia Yes 
Conjunctivitis No 
Leucopenia No 
Thrombocytopenia No 
Elevated liver enzymes ALT 58 U/L 
Viral investigation
1st sample (days post onset) 13 
Zika virus RT-PCR blood  
RT-PCR urine NS 
IgMa +128 
IgGb +512 
Dengue virus RT-PCR blood  
RT-PCR urine NS 
IgM  
IgG +64 
Chikungunya virus RT-PCR blood  
RT-PCR urine NS 
IgM  
IgG  
2nd sample (days post onset) 25 days 
Zika virus IgM +64 
IgG +1024 
Dengue virus IgM  
IgG +64 
3rd sample (days post onset)   
Zika virus IgM NS 
IgG NS 
Dengue virus IgM NS 
IgG NS 
(+) positive; () negative; Ct: cycles threshold; ND: not determined; NS: not sampled.
a IgM cut-off value 16.
b IgG cut-off value 32.rash, more prominent on the forearms and thighs with mild
conjunctival hyperemia. In the ER, on the fourth day of illness, she
was afebrile and hemodynamically stable. Basic laboratory workup
did not revealed leukopenia, thrombocytopenia or abnormal liver
enzymology. The fever continued for eight days in total, with bi-daily
peaks. The rash remained from the second to the sixth day of illness,
as well as myalgias. Differential serological diagnosis was requested
for Trypanosoma sp., Chikungunya, Dengue and Zika viruses. The
serology (ELISA) for Trypanosoma sp. was negative. Real-time PCR in
urine and IgG serology were positive for Zika virus.
The patient had only symptomatic treatment with paracetamol
and full recovery without sequel. She kept her long term
medication with chloroquine sulphate, digoxin, candesartan,
carvedilol, furosemide, trazodone, duloxetine and alopurinol.
Case 4
A 57 year old Portuguese man, with no past medical history,
presented on December 7 2015 complaining of chills, generalized
asthenia and myalgia and rash, one day after returning from Rio de
Janeiro after a 10 day stay. The study in the hospital revealedgical, clinical and virological data.
Case 2 Case 3 Case 4
Female Female Male
59 years 62 years 57 years
26 Jun. 2015 22 Nov. 2015 6 Dec. 2015
19 Jun. 2015 22 Nov. 2015 7 Dec. 2015
3 days 8 days 5 days
Hands, wrists
and ankles
Discrete 
No Yes Generalized
Maculopapular:
lower limbs
Maculopapular:
forearms and thighs
Maculopapular:
generalized
Yes No No
No No Yes
No Yes No
No No No
No No 126 000/mL
ALT 52 U/L No No
13 8 9
 NS 
NS +(Ct = 34.76) +(Ct = 34.57)
+64  
+512 +262,144 
 NS 
NS  
  
+256 +131,072 
  
NS NS ND
  
  
25 days 11 days
+32 NS +32
+512 NS 
 NS +16
+128 NS 

NS NS +32
NS NS +64
NS NS 
NS NS 
Fig. 1. Maximum likelihood phylogeny of Zika virus sequences imported from Brazil to Portugal, 2015. Maximum-likelihood phylogenetic tree was inferred based on partial
non-structural protein (NS5) nucleotide sequences (205 bp) by using Molecular Evolutionary Genetics Analysis (MEGA) version 6 software. Distance matrices were calculated
using Kimura two-parameter model with invariant sites. Bootstrap values obtained from 1000 replicate trees are shown for key nodes. Scale is shown at the bottom as
substitutions per site. The Asian cluster is shown in blue and the African clusters as dark and light gray. The sequences derived from the imported cases of Zika virus are
highlighted in blue.
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liver enzymology. Real-time PCR was positive for Zika virus in the
urine sample.
The patient received supportive treatment, improving clinically
to symptoms free.
Previous ﬂavivirus infections and vaccination against ﬂavi-
viruses (yellow fever, tick-borne encephalitis and Japanese
encephalitis viruses) were not reported by any of the patients.
The data of these four imported cases to Portugal is summarized in
Table 1.
Molecular and serologic diagnostics
In the National Institute of Health, sera samples were tested by
immunoﬂuorescent assay (IFA) in-house (IgG and IgM) for Zika
virus (ZIKV), Dengue (DENV) and Chikungunya viruses (CHIKV)
(Table 1). The presence of immunoglobulins speciﬁc to other
ﬂaviviruses, such as yellow fever (YFV), tick-borne encephalitis
(TBEV) and West Nile (WNV) viruses was also tested by IFA and all
assay results were negative for IgM and presented cross-reaction
signals in IgG.
Nucleic acids were extracted from 400 mL of ethylenediami-
netetraacetic acid (EDTA) blood samples and 900 mL urine samples
using NucliSens easyMAG platform (BioMe´rieux). The presence of
ZIKV RNA was checked by real-time RT-PCR [14] and conventional
reverse transcription-polymerase chain reaction (RT-PCR) usingZika speciﬁc primers [15] and pan-ﬂavivirus primers [16] targeting
the non-structural protein 5 (NS5) gene. The presence of DENV and
CHIKV RNA was checked by real-time PCR as reported previously
[16], and by conventional RT-PCR [17], respectively. For cases 1 and
2, Zika RT-PCR was negative (conventional and real time RT-PCR)
on blood samples collected on day 13 post onset of disease. For
cases 3 and 4, real time RT-PCR and conventional RT-PCR were
positive in urine samples on day 8 and 9 post onset, respectively.
The nested- PCR fragments (overlapping NS5, 205 bp) was
sequenced bi-directionally and submitted to GenBank (accession
numbers KU752544 and KU752545). Similarity searches were
made within the GenBank data set using the basic local alignment
search tool (BLAST) BLASTN algorithm [18]. Maximum likelihood
analysis was performed with Kimura two-parameter model with
invariant sites using Mega version 6 software [19]. The robustness
of the nodes was tested by 1000 bootstrap replications.
Discussion
In the reported cases 1 and 2, although not conﬁrmed by
molecular detection, the compatible clinical criteria, the presence
of IgM only for ZIKV, and the observed seroconversion (although
not with a four-fold or greater change antibody titers in paired
sera) proves the detection of two primary ﬂavivirus infections. Zika
virus infection in case 3 was evident by the positive urine sample
by PCR identiﬁed as belonging to the Asian lineage (Fig. 1). This was
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only ZIKV strain previously worked (MR 766) belongs to the
African lineage, ruling out any possibility of PCR contamination.
Besides the molecular diagnosis, the serological results with high
positive IgG values (262,144 for ZIKV and 131,072 for DENV; cut-
off = 32) and negative IgM titers (cut-off = 16), strongly suggest a
secondary infection by ZIKV after a probable primary DENV
infection. Cross-reaction IgG antibody titers were much lower for
other ﬂaviviruses (4096 for YFV, TBEV and WNV). In case 4 the ﬁrst
sample, RT-PCR for ZIKV was positive in urine (9 days post onset)
and negative in blood. Seroconversion was observed in the second
and third samples, ﬁrstly by only IgM positive detection (11 days
post onset) followed by IgG detection (52 days post onset).
Clinicians’ awareness in including Zika virus, along with dengue
and chikungunya viruses in differential diagnoses to patients with
febrile syndromes and rash with compatible travel history is vital
to enhanced vigilance and promptly detect ZIKV imported cases.
On the other hand, as previously noted [20], although imported
Zika infection in returned travelers is usually mild, the possibility
of sexual transmission and the eventual association with several
congenital malformations and microcephaly, still under investiga-
tion, raises concern among pregnant and fertile female travelers.
Proper advice regarding diagnosis should be provided to pregnant
women, as proper perinatal care to all who test positive for Zika
virus.
Conclusion
The rapid and ongoing spread of ZIKV in the Americas and South
Paciﬁc increases the ZIKV importation in the EU and the risk of
autochthonous transmission in regions where Aedes mosquitoes
are establish. In Portugal, this risk is increased given the historical
relations between Portugal and Brazil with high trade and travel.
Madeira Island is the only region in the EU with established
population of Aedes aegypti where it was detected for the ﬁrst time
in 2004. In 2012 a dengue outbreak was reported in Madeira [16]
most likely imported from Venezuela that is also one of the
countries with ongoing Zika outbreak.
The potential epidemiological association of ZIKV infection
with severe complications in regions with previous DENV
epidemics as Madeira Island and the future increase of imported
Zika cases to Europe urge to enhance vector surveillance and
awareness among health professionals in this region.
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